RCS - IP Group PLC - Portfolio company Hysata completes funding round

IPAnnouncement

02/08/2022 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220802:nRSB5253Ua&default-theme=true

RNS Number : 5253U  IP Group PLC  02 August 2022

 FOR RELEASE ON  02 August 2022

 

IP Group plc - Portfolio company Hysata completes oversubscribed series A
funding round to develop pilot manufacturing facility

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops
world-changing science and technology businesses across life sciences,
technology and cleantech, notes that portfolio company Hysata Pty Ltd
("Hysata" or "the Company") has raised $A42.5m (£24.3m*) to help develop a
pilot manufacturing facility aimed at delivering the world's lowest cost green
hydrogen.

Hysata, an Australian electrolyser company developing a completely new type of
electrolyser featuring the world's most efficient electrolysis cell, launched
last year having spun out of the University of Wollongong. The Hysata
electrolyser operates at 95% system efficiency (41.5 kWh/kg), delivering a
leap in performance and cost over incumbent technologies, which typically
operate at 75% or less. This high efficiency, coupled with the simple approach
to mass manufacturing and low supply chain risk puts the company on a path to
delivering the world's lowest cost green hydrogen.

IP Group committed a total of A$19m (£10.9m*) to the funding round
(A$9m(£5.1m*) from IP Group Australia and A$10m (£5.7m*) from our cleantech
platform, Kiko Ventures). Following completion, the Group's stake in Hysata is
valued at approximately £19.0m. IP Group has recorded a net unrealised fair
value gain of approximately £8.4m.

Greg Smith, Chief Executive Officer of IP Group, said: "Hysata has made
excellent technical progress with research in Nature Communications, the
scientific journal, confirming its efficiency earlier this year and we're
delighted to see Hysata attract such strong interest in this round. This is a
great example of IP Group's model where our Australian team have worked
closely with our cleantech team in the UK to find, fund and support this
exciting hydrogen technology."

The full release follows below.

*GBP equivalent using 1.75 AUD/GBP

For more information, please contact:

 

 IP Group plc                                             www.ipgroupplc.com (http://www.ipgroupplc.com)
 Liz Vaughan-Adams, Communications                        +44 (0) 20 7444 0062/+44 (0) 7967 312125
 Charlotte Street Partners
 David Gaffney                                            +44 (0) 7854 609998
 Andrew Wilson                                            +44 (0) 7810 636995

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across
life sciences, technology and cleantech (through Kiko Ventures). The Group has
a strong track record of success, having been the founder investor in a number
of high-profile companies including Oxford Nanopore Technologies plc, and has
one of the most exciting portfolios of high-growth businesses in Europe. The
Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs
world-changing technologies emerging from the UK's leading universities and
research institutions. IP Group is listed on the Main Market of the London
Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

 

Green hydrogen company Hysata's Series A funding exceeds $40 million

 

The Clean Energy Finance Corporation, Kiko Ventures, IP Group Australia,
Vestas Ventures, and Hostplus are among the top-tier investors supporting
Hysata's Capillary-Fed Electrolyser

 

(Sydney, Australia) Tuesday 2 August 2022

 

Australian company Hysata's world-leading hydrogen electrolyser technology has
been supported by renowned global investors, as the organisation closes its
oversubscribed Series A funding round of $42.5 million AUD. Virescent Ventures
led the funding round on behalf of the Clean Energy Finance Corporation (CEFC)
(Aus), with participation from Kiko Ventures (UK), IP Group Australia, Vestas
Ventures (Denmark), Hostplus (Aus) and BlueScope (via its ventures arm
BlueScopeX (TM)) (Aus).

 

Assembling such a high profile and high impact list of investors underlines
the significance of the transformation that Hysata is bringing to the green
hydrogen industry. The Hysata electrolyser operates at 95% system efficiency
(41.5 kWh/kg), delivering a giant leap in performance and cost over incumbent
technologies, which typically operate at 75% or less. This high efficiency,
coupled with the simple approach to mass manufacturing and low supply chain
risk puts the company on a path to delivering the world's lowest cost green
hydrogen.

 

Funding from the Series A round will be used to grow the Hysata team and
develop a pilot manufacturing facility.

 

"Our mission is to redefine the economics of green hydrogen production through
our innovative proprietary electrolyser technology. The support of this
international syndicate of clean energy practitioners and investors validates
our core technology and our approach to scaling and mass manufacture," said
Paul Barrett, CEO of Hysata.

 

"Green hydrogen is a vital energy vector on the world's path to net zero,
critical to decarbonising the hard-to-abate, yet vital, sectors of our economy
such as steelmaking, heavy transport, and the chemical industry. The extensive
end use cases for green hydrogen translate to a greater than trillion-dollar
market opportunity.

 

"Over the last 12-18 months, Hysata has been interacting with dozens of major
customers globally. The impact our efficiency and system simplicity delivers
to customers' project economics truly moves the needle. We look forward to
continuing to work with our shareholders and customers to bring this much
needed technology to market as soon as possible."

 

The CEFC invested $10 million into the Series A funding round, building on its
initial $750,000 investment in the early commercial development of Hysata's
research. CEFC CEO Ian Learmonth said that backing a company like Hysata and
its cutting-edge electrolyser technology is vital in helping to grow
Australia's clean technology ecosystem.

 

"The CEFC is proud to continue our support for Hysata, which is set to be a
major player in the global electrolyser industry. Green hydrogen will be
essential to addressing the hardest to abate sources of emissions, and we're
excited to see Australian ingenuity providing the technology solutions that
will help this industry reach scale. The CEFC has a strong focus on hydrogen
related investments through both our Innovation and Advancing Hydrogen Funds
and we are delighted to see Hysata continue to advance hydrogen to help meet
future energy needs and reduce emissions in more sectors of the Australian
economy," Mr Learmonth said.

 

The CEFC investment is via its specialist Clean Energy Innovation Fund, which
is managed by Virescent Ventures. Virescent Ventures Partner Blair Pritchard
said: "Hysata continues to make rapid progress and we are pleased to support
such an innovative company with an outstanding team. The continued growth of
Hysata is an important pointer to the enormous potential of hydrogen to our
net zero future."

Kiko Ventures' Founding Partner, Robert Trezona, said Hysata has real
potential to become a major global clean technology player.

 

"Having assessed scores of electrolyser technologies in my 20 years in
cleantech, Hysata's technology stands out as a true breakthrough. The company
has redefined the core cell architecture for alkaline electrolysis, producing
a practical and scalable solution with game changing efficiency. Hysata has
the potential to be a globally significant company in the hydrogen economy and
we look forward to supporting its growth, especially here in Europe." Dr
Trezona said.

 

IP Group Australia's Managing Director, Michael Molinari, added: "Hysata have
assembled a world-class team to bring their revolutionary capillary-fed
electrolyser to market. We're proud to have supported the company from before
inception at the University of Wollongong to now redefining the economics of
green hydrogen with their electrolyser that is set to scale."

 

Todd O'Neill, CEO of Vestas Ventures, said: "As the venture capital arm of the
world's leading renewable technology provider, Vestas Ventures foresees great
potential in combining wind power with electrolysers for green hydrogen
production. We are delighted to have been invited to invest in Hysata.
Nurturing disruptive renewable technologies is central to our investment
strategy and we look forward to following Hysata's success over the coming
years."

 

BlueScopeX(TM)'s General Partner, Michael Quinn, agreed that Hysata's
technology could play a significant role in the development of commercially
viable hydrogen production.

 

"BlueScopeX(TM) is pleased to be investing in Australian technologies coming
out of our local communities, with Hysata being born in the Illawarra. Our
industry requires smart, affordable technologies like Hysata's to help
progress the broader goal of decarbonisation, and we are excited to be
supporting them on their path to commercialisation," he said.

 

ENDS

 

About Hysata

Hysata is an Australian electrolyser company which is developing a completely
new type of electrolyser, featuring the world's most efficient electrolysis
cell coupled with a simplified balance of plant. Electricity makes up most of
the cost of green hydrogen and therefore, the most efficient electrolyser will
deliver the lowest cost hydrogen. The Hysata founding team comprises
electrolyser industry veterans, with deep expertise in the design and scale-up
of novel electrolysers. Building on that foundation we are growing a
world-class engineering, manufacturing, and commercial team with a footprint
on multiple continents. Backed by leading global investors, Hysata is moving
rapidly towards manufacturing at the multi-gigawatt scale needed to address
climate change. For more information visit www.hysata.com
(http://www.hysata.com)

 

About the CEFC

The CEFC has a unique mission to accelerate investment in Australia's
transition to net zero emissions. We invest to lead the market, operating with
commercial rigour to address some of Australia's toughest emissions
challenges. We're working with our co-investors across renewable energy
generation and energy storage, as well as agriculture, infrastructure,
property, transport and waste. Through the Advancing Hydrogen Fund, we're
supporting the growth of a clean, innovative, safe and competitive hydrogen
industry. And as Australia's largest dedicated cleantech investor, we continue
to back cleantech entrepreneurs through the Clean Energy Innovation Fund. With
$10 billion to invest on behalf of the Australian Government, we work to
deliver a positive return for taxpayers across our portfolio.

 

About Virescent Ventures

Virescent Ventures was born out of the Clean Energy Innovation Fund
(https://www.cefc.com.au/where-we-invest/special-investment-programs/clean-energy-innovation-fund/)
, part of the Clean Energy Finance Corporation (https://www.cefc.com.au/) .
Virescent invests in pre-seed to late-stage growth capital, and makes
investments that address the largest, hardest to abate sources of emissions.
For more information visit www.virescent.vc (http://www.virescent.vc)

 

About Kiko Ventures

Kiko Ventures is a US$450m venture investor that supports transformative
climate tech and is the world's first evergreen cleantech VC. Launched in 2022
by the FTSE 250 listed investment firm IP Group plc, Kiko Ventures was founded
to create new possibilities for a regenerative future. It is a highly flexible
investment platform using IP Group's balance sheet capital and aims to be a
long-term partner to leading climate tech innovators.

For more information visit www.kiko.vc (http://www.kiko.vc)

 

About IP Group Australia

IP Group develops world-changing science and technology businesses across life
sciences, technology and cleantech. The Group has a strong track record of
success, having been the founder investor in a number of high-profile
companies including Oxford Nanopore Technologies plc. In Australia and New
Zealand, IP Group works in close partnership with the Go8 Universities and the
University of Auckland to identify ground-breaking technologies rooted in hard
science, which have the most promising commercial potential. IP Group is
listed on the Main Market of the London Stock Exchange under the code
IPO. For more information visit www.ipgroupanz.com
(http://www.ipgroupanz.com/)

 

About Vestas Ventures

Vestas Ventures is the corporate venture capital arm of Vestas Wind Systems,
the world's leading renewable technology provider. Vestas Ventures invests in
startups that support Vestas' vision to be the global leader in sustainable
energy solutions. For more information visit www.vestas.com/ventures
(http://www.vestas.com/ventures)

 

About Hostplus

Hostplus has grown to be one of the largest industry super funds in Australia.
With over 1.5 million members, more than 269,000 employers and $86.6 billion
in funds under management (as at 30 June 2022), our scale and ongoing growth
allows for low member costs and a broad range of investment opportunities.

 

For more information visit www.hostplus.com.au (http://www.hostplus.com.au)

 

About BlueScopeX(TM)

BlueScope is one of the world's leading manufacturers steel coated products
and commercial steel buildings. BlueScope is publicly listed on the Australian
Stock Exchange, with an approximate market cap of $10b and >14,000
employees globally.

 

BlueScopeXTM is the ventures arm of BlueScope, dedicated to investing in and
accelerating start-ups and businesses developing technologies and solutions in
the decarbonisation space, and efficiency improvements in the built
environment. For more information visit www.bluescope.com
(http://www.bluescope.com/)

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAPBMRTMTBMBBT